innovation
Enodia Therapeutics: €20.7 million in funding to translate Institut Pasteur discovery into innovative therapies
Enodia Therapeutics, a startup spun out from Institut Pasteur and launched in February 2025, has raised €20.7 million in a seed funding round co-led by Elaia, Pfizer Ventures, and Bpifrance through its InnoBio fund, with participation from Wallonie Entreprendre, Argobio Studio, MACSF, the Institut Pasteur, InvestSud, Sambrinvest and Mission BioCapital. The successful funding round, which attracted a wide range of prestigious investors, reflects the Institut Pasteur's ability to transform foundational research into groundbreaking therapeutic innovation.
Image
Well, that's exactly what researchers at the Institut Pasteur have discovered.
A toxin responsible for a tropical disease is now at the heart of a medical revolution.
Delve into this incredible story of science and innovation.
Discover how Caroline Demangel's team at the Institut Pasteur
is transforming this toxin into an innovative treatment.